Geode Capital Management’s TransCode Therapeutics RNAZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-121,768
| Closed | -$69.5K | – | 4501 |
|
|
2024
Q3 | $69.5K | Buy |
121,768
+83,370
| +217% | +$47.6K | ﹤0.01% | 4193 |
|
|
2024
Q2 | $38.6K | Buy |
+38,398
| New | +$38.6K | ﹤0.01% | 4332 |
|
|
2024
Q1 | – | Sell |
-52,232
| Closed | -$8.61K | – | 4633 |
|
|
2023
Q4 | $8.61K | Buy |
+52,232
| New | +$8.61K | ﹤0.01% | 4600 |
|
|
2023
Q2 | – | Sell |
-75,683
| Closed | -$25.6K | – | 4779 |
|
|
2023
Q1 | $25.6K | Sell |
75,683
-866
| -1% | -$293 | ﹤0.01% | 4657 |
|
|
2022
Q4 | $51K | Hold |
76,549
| – | – | ﹤0.01% | 4586 |
|
|
2022
Q3 | $84K | Hold |
76,549
| – | – | ﹤0.01% | 4631 |
|
|
2022
Q2 | $96K | Buy |
76,549
+5,277
| +7% | +$6.62K | ﹤0.01% | 4610 |
|
|
2022
Q1 | $205K | Hold |
71,272
| – | – | ﹤0.01% | 4370 |
|
|
2021
Q4 | $181K | Buy |
71,272
+54,249
| +319% | +$138K | ﹤0.01% | 4521 |
|
|
2021
Q3 | $50K | Buy |
+17,023
| New | +$50K | ﹤0.01% | 4779 |
|